BioSpace News Archive

Excite Medical, the manufacturer of the revolutionary DRX9000™ spinal decompression machine, is announcing two new dates for their Spinal Decompression Marketing Workshop in Tampa, FL.

The Leukemia & Lymphoma Society announced that the first patient was dosed in a clinical trial investigating whether a shorter course of combination therapy is less toxic while remaining as effective as the FDA-approved regimen in older patients with newly diagnosed acute myeloid leukemia.

Acasti Pharma Inc. today announced the appointment of W. Taylor Kimberly , MD, PhD, Alejandro A. Rabinstein, MD and Sherry H-Y. Chou, MD to its Scientific Advisory Board.

Ansys, the global leader and innovator of engineering simulation software, is establishing its first physical presence in Africa with a new office in Kigali, Rwanda.

Spaulding Clinical, a leading clinical research organization, is expanding its services to include ADME clinical trials.

Tvardi Therapeutics, Inc. today announced that the first patients have been dosed in each arm of its ongoing REVERT LIVER CANCER trial.

Beta Bionics, Inc. - a medical technology company focused on diabetes - announces FDA 510(k) clearance for compatibility with the Fiasp Pumpcart (insulin aspart) prefilled insulin cartridge.

Propanc Biopharma, Inc. today announced a shareholder update including recent developments and forecast for 2023/24, as Propanc prepares to file a Form 10-K annual report, whose fiscal year end is June 30.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that its groundbreaking research utilizing DehydraTECH-processed cannabidiol (“DehydraTECH-CBD”) has now been published in eight peer-reviewed articles in six different publications.

Management to Host Conference Call at 8:00 Am Eastern Time on Thursday, June 22, 2023